Literature DB >> 25274777

Viral-mediated vision rescue of a novel AIPL1 cone-rod dystrophy model.

Cristy A Ku1, Vince A Chiodo2, Sanford L Boye2, Abigail Hayes3, Andrew F X Goldberg4, William W Hauswirth2, Visvanathan Ramamurthy5.   

Abstract

Defects in aryl hydrocarbon receptor interacting protein-like1 (AIPL1) are associated with blinding diseases with a wide range of severity in humans. We examined the mechanism behind autosomal dominant cone-rod dystrophy (adCORD) caused by 12 base pair (bp) deletion at proline 351 of hAIPL1 (P351Δ12) mutation in the primate-specific region of human AIPL1. Mutant P351Δ12 human isoform, aryl hydrocarbon receptor interacting protein-like 1 (hAIPL1) mice demonstrated a CORD phenotype with early defects in cone-mediated vision and subsequent photoreceptor degeneration. A dominant CORD phenotype was observed in double transgenic animals expressing both mutant P351Δ12 and normal hAIPL1, but not with co-expression of P351Δ12 hAIPL1 and the mouse isoform, aryl hydrocarbon receptor interacting protein-like 1 (mAipl1). Despite a dominant effect of the mutation, we successfully rescued cone-mediated vision in P351Δ12 hAIPL1 mice following high over-expression of WT hAIPL1 by adeno-associated virus-mediated gene delivery, which was stable up to 6 months after treatment. Our transgenic P351Δ12 hAIPL1 mouse offers a novel model of AIPL1-CORD, with distinct defects from both the Aipl1-null mouse mimicking LCA and the Aipl1-hypomorphic mice mimicking a slow progressing RP.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25274777      PMCID: PMC4357806          DOI: 10.1093/hmg/ddu487

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  29 in total

1.  Gene therapy using self-complementary Y733F capsid mutant AAV2/8 restores vision in a model of early onset Leber congenital amaurosis.

Authors:  Cristy A Ku; Vince A Chiodo; Sanford L Boye; Andrew F X Goldberg; Tiansen Li; William W Hauswirth; Visvanathan Ramamurthy
Journal:  Hum Mol Genet       Date:  2011-08-31       Impact factor: 6.150

2.  The mouse Crx 5'-upstream transgene sequence directs cell-specific and developmentally regulated expression in retinal photoreceptor cells.

Authors:  Akiko Furukawa; Chieko Koike; Pia Lippincott; Constance L Cepko; Takahisa Furukawa
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

3.  Prevalence of AIPL1 mutations in inherited retinal degenerative disease.

Authors:  M M Sohocki; I Perrault; B P Leroy; A M Payne; S Dharmaraj; S S Bhattacharya; J Kaplan; I H Maumenee; R Koenekoop; F M Meire; D G Birch; J R Heckenlively; S P Daiger
Journal:  Mol Genet Metab       Date:  2000-06       Impact factor: 4.797

4.  Mutations in a new photoreceptor-pineal gene on 17p cause Leber congenital amaurosis.

Authors:  M M Sohocki; S J Bowne; L S Sullivan; S Blackshaw; C L Cepko; A M Payne; S S Bhattacharya; S Khaliq; S Qasim Mehdi; D G Birch; W R Harrison; F F Elder; J R Heckenlively; S P Daiger
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

5.  Unique proline-rich domain regulates the chaperone function of AIPL1.

Authors:  Jing Li; Gabriel Zoldak; Thomas Kriehuber; Joanna Soroka; Franz X Schmid; Klaus Richter; Johannes Buchner
Journal:  Biochemistry       Date:  2013-03-13       Impact factor: 3.162

6.  Evaluation of Italian patients with leber congenital amaurosis due to AIPL1 mutations highlights the potential applicability of gene therapy.

Authors:  Francesco Testa; Enrico Maria Surace; Settimio Rossi; Elena Marrocco; Annagiusi Gargiulo; Valentina Di Iorio; Carmela Ziviello; Anna Nesti; Simona Fecarotta; Maria Laura Bacci; Massimo Giunti; Michele Della Corte; Sandro Banfi; Alberto Auricchio; Francesca Simonelli
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

7.  The phenotype of Leber congenital amaurosis in patients with AIPL1 mutations.

Authors:  Sharola Dharmaraj; Bart P Leroy; Melanie M Sohocki; Robert K Koenekoop; Isabelle Perrault; Khalid Anwar; Shagufta Khaliq; R Summathi Devi; David G Birch; Elaine De Pool; Natalio Izquierdo; Lionel Van Maldergem; Mohammad Ismail; Annette M Payne; Graham E Holder; Shomi S Bhattacharya; Alan C Bird; Josseline Kaplan; Irene H Maumenee
Journal:  Arch Ophthalmol       Date:  2004-07

8.  A short, highly active photoreceptor-specific enhancer/promoter region upstream of the human rhodopsin kinase gene.

Authors:  Joyce E Young; Todd Vogt; Kenneth W Gross; Shahrokh C Khani
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-09       Impact factor: 4.799

9.  Leber congenital amaurosis linked to AIPL1: a mouse model reveals destabilization of cGMP phosphodiesterase.

Authors:  Visvanathan Ramamurthy; Gregory A Niemi; Thomas A Reh; James B Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

10.  Leber congenital amaurosis associated with AIPL1: challenges in ascribing disease causation, clinical findings, and implications for gene therapy.

Authors:  Mei Hong Tan; Donna S Mackay; Jill Cowing; Hoai Viet Tran; Alexander J Smith; Genevieve A Wright; Arundhati Dev-Borman; Robert H Henderson; Phillip Moradi; Isabelle Russell-Eggitt; Robert E MacLaren; Anthony G Robson; Michael E Cheetham; Dorothy A Thompson; Andrew R Webster; Michel Michaelides; Robin R Ali; Anthony T Moore
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

View more
  5 in total

1.  Bardet-Biedl syndrome-8 (BBS8) protein is crucial for the development of outer segments in photoreceptor neurons.

Authors:  Tanya L Dilan; Ratnesh K Singh; Thamaraiselvi Saravanan; Abigail Moye; Andrew F X Goldberg; Peter Stoilov; Visvanathan Ramamurthy
Journal:  Hum Mol Genet       Date:  2018-01-15       Impact factor: 6.150

Review 2.  CLINICAL PROGRESS IN INHERITED RETINAL DEGENERATIONS: GENE THERAPY CLINICAL TRIALS AND ADVANCES IN GENETIC SEQUENCING.

Authors:  Brian P Hafler
Journal:  Retina       Date:  2017-03       Impact factor: 4.256

3.  Clinical and functional analyses of AIPL1 variants reveal mechanisms of pathogenicity linked to different forms of retinal degeneration.

Authors:  Almudena Sacristan-Reviriego; Hoang Mai Le; Michalis Georgiou; Isabelle Meunier; Beatrice Bocquet; Anne-Françoise Roux; Chrisostomos Prodromou; James Bainbridge; Michel Michaelides; Jacqueline van der Spuy
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

4.  Gene Therapy in a Large Animal Model of PDE6A-Retinitis Pigmentosa.

Authors:  Freya M Mowat; Laurence M Occelli; Joshua T Bartoe; Kristen J Gervais; Ashlee R Bruewer; Janice Querubin; Astra Dinculescu; Sanford L Boye; William W Hauswirth; Simon M Petersen-Jones
Journal:  Front Neurosci       Date:  2017-06-20       Impact factor: 5.152

5.  ARL2BP, a protein linked to retinitis pigmentosa, is needed for normal photoreceptor cilia doublets and outer segment structure.

Authors:  Abigail R Moye; Ratnesh Singh; Victoria A Kimler; Tanya L Dilan; Daniella Munezero; Thamaraiselvi Saravanan; Andrew F X Goldberg; Visvanathan Ramamurthy
Journal:  Mol Biol Cell       Date:  2018-05-02       Impact factor: 4.138

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.